Miguel Angel Arias
Overview
Explore the profile of Miguel Angel Arias including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bazan V, Arana E, Rubio-Campal J, Calvo D, Alvarez Acosta L, Hernandez Afonso J, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Sep;
77(12):1026-1036.
PMID: 39313188
Introduction And Objectives: We report the results of the 2023 Spanish catheter ablation registry. Methods: Procedural data were collected and incorporated into the REDCap platform by all participating centers through...
2.
Rodriguez Munoz D, Ramos Jimenez J, Marco Del Castillo A, Lozano Granero C, Garcia Alberola A, Jimenez Sanchez D, et al.
Am Heart J
. 2023 Dec;
269:15-24.
PMID: 38042457
Background And Objective: Patients with palpitations clinically suggestive of paroxysmal supraventricular tachycardia (PSVT) are often managed conservatively until ECG-documentation of the tachycardia, leading to high impact on life quality and...
3.
Bisbal F, Abugattas J, Trotta O, Gonzalez-Ferrer J, Sauri-Ortiz A, Angel Arias M, et al.
Heart Rhythm O2
. 2023 Jan;
3(6Part A):656-664.
PMID: 36589911
Background: Atrial fibrillation (AF) ablation strategy is associated with a non-negligible risk of complications and often requires repeat procedures (AF ablation track), implying repetitive exposure to procedural risk. Objective: The...
4.
El Amrani A, Vinolas X, Angel Arias M, Bazan V, Valdovinos P, Alegret J
J Clin Med
. 2021 Apr;
10(5).
PMID: 33802253
Background: Antiarrhythmic drugs (AADs) are frequently initiated in patients with persistent atrial fibrillation (AF) prior to electrical cardioversion (ECV), achieving pharmacological cardioversion (PCV) in some cases. Little is known about...
5.
Boriani G, Pisano E, Pieragnoli P, Locatelli A, Capucci A, Talarico A, et al.
Heart Rhythm
. 2020 Dec;
18(3):374-381.
PMID: 33283757
Background: Sleep apnea, as measured by polysomnography, is associated with adverse outcomes in heart failure. The DASAP-HF (Diagnosis and Treatment of Sleep Apnea in Patient With Heart Failure) study previously...
6.
Rodriguez-Padial L, Angel Arias M
Rev Esp Cardiol (Engl Ed)
. 2020 Oct;
73(12):1084-1085.
PMID: 33060066
No abstract available.
7.
Rodriguez-Padial L, Angel Arias M
Rev Esp Cardiol
. 2020 Aug;
73(12):1084-1085.
PMID: 32836668
No abstract available.
8.
Ferreira-Gonzalez I, Sanchez-Recalde A, Abu-Assi E, Angel Arias M, Gallego P, Del Rio I
Rev Esp Cardiol (Engl Ed)
. 2020 Apr;
73(5):410-417.
PMID: 32291243
No abstract available.
9.
Cabanas-Grandio P, Campo E, Bisbal F, Garcia-Seara J, Pachon M, Juan-Salvadores P, et al.
J Cardiovasc Electrophysiol
. 2019 Dec;
31(1):330-336.
PMID: 31840881
Background: Leadless pacemakers (L-PM) are an emerging effective and safe technology that offer an alternative to conventional pacemakers (C-PM) for right ventricular stimulation. However, there is little information about their...
10.
Fontenla A, Lopez-Gil M, Tamargo-Menendez J, Matia-Frances R, Salgado-Aranda R, Rey-Blas J, et al.
Rev Esp Cardiol (Engl Ed)
. 2019 Oct;
73(5):368-375.
PMID: 31631048
Introduction And Objectives: Ivabradine is an inhibitor of the If channel, the main determinant of the pacemaker function of the sinus node. The drug has been approved for the treatment...